BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33153913)

  • 1. Access to clinical pharmacy services in a pharmacist-physician covisit model.
    Ulrich IP; Lugo B; Hughes P; Doucette L; Creith BB; Flanagan S; Gilmer B
    Res Social Adm Pharm; 2021 Jul; 17(7):1321-1326. PubMed ID: 33153913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a pharmacist-physician covisit model in a family medicine practice.
    Ulrich IP; Patel S; Gilmer B
    J Am Pharm Assoc (2003); 2019; 59(1):129-135. PubMed ID: 30416066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and implementation of ambulatory care pharmacy services at an internal medicine clinic.
    Wells C; Warren AC; Ashe Scott M
    Am J Health Syst Pharm; 2024 Apr; ():. PubMed ID: 38613410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare Annual Wellness Visits: A Scoping Review of Current Practice Models and Opportunities for Pharmacists.
    Hohmann LA; Hastings TJ; Qian J; Curran GM; Westrick SC
    J Pharm Pract; 2020 Oct; 33(5):666-681. PubMed ID: 31232218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing pharmacist-led annual wellness visits: Interventions made and patient and physician satisfaction.
    Wilson CG; Park I; Sutherland SE; Ray L
    J Am Pharm Assoc (2003); 2015; 55(4):449-54. PubMed ID: 26161489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Pharmacist and Physician Managed Annual Medicare Wellness Services.
    Sewell MJ; Riche DM; Fleming JW; Malinowski SS; Jackson RT
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1412-1416. PubMed ID: 27882836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the impact of adding pharmacist management services to an existing discharge planning program on 30-day readmissions.
    Peasah SK; Hammond T; Campbell V; Liu Y; Morgan M; Kearney S; Good CB
    J Am Pharm Assoc (2003); 2022; 62(3):734-739. PubMed ID: 34975006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Satisfaction with Medicare Annual Wellness Visits Administered by a Clinical Pharmacist Practitioner.
    Sherrill CH; Cavanaugh J; Shilliday BB
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1125-1129. PubMed ID: 29083974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health Economic Analysis of Pharmacist-Led Annual Wellness Visits.
    Mallouh MA; Briggs A; Hawkins S; Heffern C
    Sr Care Pharm; 2023 May; 38(5):185-192. PubMed ID: 37185146
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of Physician-Pharmacist Covisits at a Primary Care Clinic in Patients With Uncontrolled Diabetes.
    Peterson J; Hinds A; Garza A; Barner J; Hill L; Nguyen M; Lai P; Gums T
    J Pharm Pract; 2020 Jun; 33(3):321-325. PubMed ID: 30428760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community pharmacist-delivered Medicare Annual Wellness Visits within a family medicine practice.
    Evans TA; Fabel PH; Ziegler B
    J Am Pharm Assoc (2003); 2017; 57(3S):S247-S251. PubMed ID: 28400254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Interventions in Clinical Pharmacist-Led Annual Medicare Wellness Visits Compared with Usual Care.
    Beliard RC; Merrey JW
    Consult Pharm; 2017 Nov; 32(11):687-699. PubMed ID: 29113636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial implications of pharmacist-led Medicare annual wellness visits.
    Park I; Sutherland SE; Ray L; Wilson CG
    J Am Pharm Assoc (2003); 2014; 54(4):435-40. PubMed ID: 25063264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pharmacist intervention in conjunction with outpatient physician follow-up visits after hospital discharge on readmission rate.
    Arnold ME; Buys L; Fullas F
    Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S36-42. PubMed ID: 25991594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using theory to predict implementation of a physician-pharmacist collaborative intervention within a practice-based research network.
    Demik DE; Vander Weg MW; Lundt ES; Coffey CS; Ardery G; Carter BL
    Res Social Adm Pharm; 2013; 9(6):719-30. PubMed ID: 23506651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced Practice Pharmacists: a retrospective evaluation of the efficacy and cost of ClinicaL Pharmacist PractitionErs managing ambulatory Medicare patients in North Carolina (APPLE-NC).
    Kislan MM; Bernstein AT; Fearrington LR; Ives TJ
    BMC Health Serv Res; 2016 Oct; 16(1):607. PubMed ID: 27769219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The design and evaluation of a pilot covisit model: Integration of a pharmacist into a primary care team.
    Roll A; Pattison D; Baumgartner R; Sublett L; Brown B
    J Am Pharm Assoc (2003); 2020; 60(3):491-496. PubMed ID: 31889652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Pharmacy Services in a Multidisciplinary Specialty Pain Clinic.
    Semerjian M; Durham MJ; Mirzaian E; Lou M; Richeimer SH
    Pain Pract; 2019 Mar; 19(3):303-309. PubMed ID: 30403432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a medication therapy management program in a primary care clinic.
    Bowers BL; Heffern C; Billings S
    J Am Pharm Assoc (2003); 2019; 59(3):383-389. PubMed ID: 30954401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a pharmacist in improving quality measures that affect payments to physicians.
    Sinclair J; Bentley OS; Abubakar A; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S85-S90. PubMed ID: 31203017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.